These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 520947)

  • 21. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
    Privitera MD
    Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concentration of benzonal in the blood of epileptic patients at different daily doses and with other anticonvulsants].
    Gromov SA; Stabrovskiĭ EM; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):855-8. PubMed ID: 3751420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of coadministered antiepileptic drugs on serum zonisamide concentrations in epileptic patients: quantitative analysis based on suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2003 Dec; 26(12):1734-8. PubMed ID: 14646181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study.
    Woo E; Chan YM; Yu YL; Chan YW; Huang CY
    Epilepsia; 1988; 29(2):129-39. PubMed ID: 3280304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Optimizing the therapeutic process in long-term antiepileptic therapy through the determination of drug levels in patients].
    Walther H; Meyer FP; Leuschner U; Quednow B; Köhler E
    Psychiatr Neurol Med Psychol (Leipz); 1978 Mar; 30(3):150-8. PubMed ID: 652872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of dose, age, and sex on the serum levels of phenobarbital and diphenylhydantoin in epileptic patients.
    Furlanut M; Benetello P; Testa G; Da Ronch A
    Pharmacol Res Commun; 1978 Jan; 10(1):85-9. PubMed ID: 643894
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma anticonvulsant concentrations during pregnancy.
    Lander CM; Edwards VE; Eadie MJ; Tyrer JH
    Neurology; 1977 Feb; 27(2):128-31. PubMed ID: 556828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
    Yukawa E
    Clin Pharmacokinet; 1996 Aug; 31(2):120-30. PubMed ID: 8853934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of blood levels of antiepileptic drugs in clinical practice.
    Kutt H
    Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906
    [No Abstract]   [Full Text] [Related]  

  • 33. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT; Wilkinson GR
    Neurology; 1974 Jul; 24(7):614-23. PubMed ID: 4858085
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
    Windorfer A; Sauer W
    Neuropadiatrie; 1977 Feb; 8(1):29-41. PubMed ID: 321985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Polytherapy and monotherapy in the treatment of epileptic patients].
    Petrone F; Cavalcanti S; Turchiaro GG; Rolando G
    Acta Neurol (Napoli); 1981 Feb; 3(1):76-84. PubMed ID: 7246321
    [No Abstract]   [Full Text] [Related]  

  • 36. Direct serum injection high-performance liquid chromatographic method for the simultaneous determination of phenobarbital, carbamazepine and phenytoin.
    Rainbow SJ; Dawson CM; Tickner TR
    J Chromatogr; 1990 May; 527(2):389-96. PubMed ID: 2201693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of epilepsy in the light of the determination of the anticonvulsant blood level].
    Majkowski J
    Neurol Neurochir Pol; 1971; 5(3):295-300. PubMed ID: 5116780
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical remarks about the monitoring of antiepileptic drug levels in pediatric age (author's transl)].
    Gaggero R; La Medica ; De Negri M
    Pediatr Med Chir; 1981; 3(2-3):151-8. PubMed ID: 6806780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-drug interactions among drugs prescribed for nontuberculous mycobacterial infection and epilepsy: A case report.
    Yoshikawa N; Tazaki T; Hatanaka M; Oda Y; Matsumoto N; Sonoda J; Ikeda R
    J Clin Pharm Ther; 2019 Feb; 44(1):119-121. PubMed ID: 30311244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.